Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use. (Q36246932)

13 August 2017

1 reference

title

Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use. (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

Shigeo Koido

1

1 reference

13 August 2017

Najmosama Nikrui

2

1 reference

13 August 2017

Masaya Ohana

3

1 reference

13 August 2017

Jianchuan Xia

4

1 reference

13 August 2017

Yasuhiro Tanaka

5

1 reference

13 August 2017

Chunlei Liu

6

1 reference

13 August 2017

John K Durfee

7

1 reference

13 August 2017

Adam Lerner

8

1 reference

13 August 2017

Jianlin Gong

9

1 reference

13 August 2017

language of work or name

English

0 references

publication date

30 August 2005

1 reference

13 August 2017

1 reference

13 August 2017

99

1 reference

13 August 2017

462-471

1 reference

13 August 2017

2

1 reference

13 August 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

The CA 125 tumour-associated antigen: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Absence of co-stimulation and not the intensity of TCR signaling is critical for the induction of T cell unresponsiveness in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

The dendritic cell system and its role in immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.019

10.1016/J.YGYNO.2005.07.019

7 January 2021

Identifiers

DOI

1 reference

13 August 2017

1 reference